Clinical Trials
3 trialsNCT07215832 2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available
NCT05619367 2025-12-23
A Compassionate Use (CU) Program of Odronextamab
Regeneron Pharmaceuticals
Available
NCT04400591 2025-12-11
Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol
Juno Therapeutics, a Subsidiary of Celgene
Available